GSK awarded favourable court ruling in Zantac trial
First Zantac trial winSecond case dismissedShares continue to recoverGSK (GSK) has won the first legal case to be heard in the ongoing Zantac litigation cases after a Chicago jury ruled in its favour and dismissed the plaintiff's claim that the drug had caused her colorectal cancer.Angela Valadez has taken Zantac and generic versions of the drug between 1995 and 2014 and was seeking $640 million i